Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

NCT02910297 is registered in ClinicalTrials.gov with Gillette Children's Specialty Healthcare as lead sponsor.

NCT NCT02910297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02910297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
Lead sponsor
Gillette Children's Specialty Healthcare
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
December 31, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome, lennox gastaut syndrome